| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |